COMP <GO>
HHS vs CCZ // RSI-14 & 200D SMA MOMENTUM
Harte Hanks Inc. (NASDAQ) VS. Comcast Holdings ZONES (NYSE) • 15-METRIC TALLY: HHS 0
— CCZ 10
▲ RSI-14 & 200D SMA MOMENTUM LEADER: CCZ
LAST: $3.86 (-3.50%) • MKT CAP: $28.8M
rsi-technicals
36.4
LAST: $64.50 (+3.12%) • MKT CAP: $229.04B
rsi-technicals
52.8
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HHS VS. CCZ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HHS | CCZ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.00% | 18.70% | -16.70 | CCZ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 8.5x | 7.2x | +1.30 | CCZ | /valuation <GO> |
| Free Cash Flow Yield | -15.61% | 9.56% | -25.17 | CCZ | /fcf-yield <GO> |
| Operating Margin | 0.20% | 16.70% | -16.50 | CCZ | /operating-margins <GO> |
| Net Profit Margin | -0.50% | 16.20% | -16.70 | CCZ | /net-margins <GO> |
| Revenue Growth (YoY) | -13.90% | 0.00% | -13.90 | CCZ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.14% | -2.14 | CCZ | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 14.61 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 5/9 | -4.00 | CCZ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 36.4 | 52.8 | -16.40 | CCZ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 10.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $28.8M | $229.04B | -$229.01B | CCZ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HHS REV | CCZ REV | HHS GROSS % | CCZ GROSS % | HHS FCF | CCZ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $159.6M | $123.71B | — | — | -$4.5M | $21.89B |
| FY 2024 | $185.2M | $123.73B | — | — | -$6.7M | $15.49B |
| FY 2023 | $191.5M | $121.57B | — | — | $10.5M | $28.50B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HHS // BETA —
CCZ // BETA —